Summary
Updated Aug 31, 2026
Gavin Wood is Chief Financial Officer of Adaptimmune Therapeutics PLC (ADAP). 1 SEC Form 4 filing on record, dated 2 September 2025. Most recent open-market trade: sold $950 of ADAP on 2 September 2025. Lifetime open-market sales: $950.
Recent Transactions
1Every recent SEC Form 4 transaction Gavin Wood has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Gavin Wood. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- EcoR1 Capital, LLC - $6.89M of ADAP open-market activity on record
- Ali Behbahani - $229K of ADAP open-market activity on record
- William C. Bertrand Jr. - $2K of ADAP open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Gavin Wood?
Gavin Wood is a corporate insider, tracked as Chief Financial Officer of Adaptimmune Therapeutics PLC (ADAP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Gavin Wood last file a Form 4?
The only primary Form 4 on record is dated 2 September 2025.
Has Gavin Wood been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($950) across all tracked filings.
Where can I see all of Gavin Wood's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Gavin Wood and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
